Container Closure Integrity of Vial Primary Packaging Systems under Frozen Storage Conditions: A Case Study

References

1. 1.↵
   1. Hamada M.

   The Industry’s Shift To 100% Non-Destructive Container Closure Integrity Testing with USP <1207>. Biosimilar Development, 2016. https://www.biosimilardevelopment.com/doc/the-industry-s-shift-to-non-destructive-container-closure-integrity-testing-with-usp-0001 (accessed May 18, 2018).
2. 2.↵
   1. Krause M. E.,
   2. Sahin E.

   Chemical and Physical Instabilities in Manufacturing and Storage of Therapeutic Proteins. Curr. Opin. Biotechnol. 2019, 60, 159–167.

   OpenUrl
3. 3.↵
   1. Hunt C. J.

   Technical Considerations in the Freezing, Low-Temperature Storage and Thawing of Stem Cells for Cellular Therapies. Transfus. Med. Hemother. 2019, 46 (3), 134–150.

   OpenUrl
4. 4.↵
   Cell Therapy Market Size, Share & Trends Analysis Report by Use-type (Research, Commercialized, Musculoskeletal Disorders), by Therapy Type (Autologous, Allogeneic), by Region, and Segment Forecasts, 2020 – 2027. https://www.globenewswire.com/fr/news-release/2020/03/05/1995611/0/en/Cell-Therapy-Market-Size-Share-Trends-Analysis-Report-By-Use-type-By-Therapy-Type-By-Region-And-Segment-Forecasts-2020-2027.html?f=22&fvtc=4&fvtv=56986
5. 5.↵
   1. Funk C. D.,
   2. Laferriere C.,
   3. Ardakani A.

   A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic. Front. Pharmacol. 2020, 11, 937.

   OpenUrl
6. 6.↵
   1. Curran O.,
   2. Vilivalam V.,
   3. Kuiper S.,
   4. Duncan D.

   BioProcess International 2013, 11(9), 42–44.
7. 7.↵
   1. Zuleger B.,
   2. Werner U.,
   3. Kort A.,
   4. Glowienka R.,
   5. Wehnes E.,
   6. Duncan D.

   Container/Closure Integrity Testing and the Identification of a Suitable Vial/Stopper Combination for Low-Temperature Storage at –80°C. PDA J. Pharm. Sci. Technol. 2012, 66 (5), 453–465.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   U.S. Pharmacopeial Convention, General Chapter <1207> Sterile Product Packaging—Integrity Evaluation. In USP 42—NF37, USP: Rockville, MD, 2019.
9. 9.↵
   Parenteral Drug Association Inc. Technical Report No. 27: Pharmaceutical Package Integrity; Bethesda, MD, 1998.
10. 10.↵
    U.S. Pharmacopeial Convention, General Chapter <381> Elastomeric Closures for Injections. In USP 42—NF37, USP: Rockville, MD, 2019.
11. 11.↵
    Council of Europe, Rubber Closures for Aqueous Parenteral Preparations, for Powders and for Freeze-Dried Powders, Chapter 3.2.9. In European Pharmacopoeia (Ph. Eur.), 9th Edition, Council of Europe, Strasbourg, France, 2017.
12. 12.↵
    1. Cummings P.,
    2. Jacobs B.

    Testing Closure Integrity at Low Temperatures, 2014. https://www.contractpharma.com/issues/2014-04-01/view_features/testing-closure-integrity-at-low-temperatures/ (accessed October 26, 2020)
13. 13.↵
    1. Nieto A.,
    2. Roehl H.,
    3. Brown H.,
    4. Nikoloff J.,
    5. Adler M.,
    6. Mahler H.-C.

    Evaluation of Container Closure System Integrity for Frozen Storage Drug Products. PDA J. Pharm. Sci. Technol. 2016, 70 (2), 120–133.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Nieto A.,
    2. Roehl H.,
    3. Adler M.,
    4. Mohl S.

    Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and Transportation. PDA J. Pharm. Sci. Technol. 2018, 72 (6), 544–552.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Mehta S. B.,
    2. Roy S.,
    3. Yang H.-C.

    ‘Product on Stopper’ in a Lyophilized Drug Product: Cosmetic Defect or a Product Quality Concern? J. Pharm. Sci. 2018, 107 (6), 1736–1740.

    OpenUrl
16. 16.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Residual Seal Force Measurement of Parenteral Vials. I. Methodology. J. Parenter. Sci. Technol. 1988, 42 (1), 23–29.

    OpenUrlPubMed
17. 17.↵
    1. Ludwig J. D.,
    2. Davis C. W.

    Automated Method for Determining Instron Residual Seal Force of Glass Vial/Rubber Closure Systems. Part II. 13 mm Vials. PDA J. Pharm. Sci. Technol. 1995, 49 (5), 253–256.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Ludwig J. D.,
    2. Nolan P. D.,
    3. Davis C. W.

    Automated Method for Determining Instron Residual Seal Force of Glass Vial/Rubber Closure Systems. J. Parenter. Sci. Technol. 1993, 47 (5), 211–253.

    OpenUrlPubMed
19. 19.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Residual Seal Force Measurements of Parenteral Vials. II. Elastomer Evaluation. J. Parenter. Sci. Technol. 1988, 42 (2), 57–61.

    OpenUrlPubMed
20. 20.↵
    1. Kirsch L. E.,
    2. Nguyen L.,
    3. Moeckly C. S.,
    4. Gerth R.

    Pharmaceutical Container/Closure Integrity. II: The Relationship between Microbial Ingress and Helium Leak Rates in Rubber-Stoppered Glass Vials. PDA J. Pharm. Sci. Technol. 1997, 51 (5), 195–202.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Mathaes R.,
    2. Mahler H.-C.,
    3. Vorgrimler L.,
    4. Steinberg H.,
    5. Dreher S.,
    6. Roggo Y.,
    7. Nieto A.,
    8. Brown H.,
    9. Roehl H.,
    10. Adler M.,
    11. Luemkemann J.,
    12. Huwyler J.,
    13. Lam P.,
    14. Stauch O.,
    15. Mohl S.,
    16. Streubel A.

    The Pharmaceutical Capping Process–Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal Force. PDA J. Pharm. Sci. Technol. 2016, 70 (3), 218–229.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Oni Y.,
    2. Song X.,
    3. Schrader M.,
    4. Kulshrestha A.,
    5. Franck J.,
    6. Asselta R.,
    7. Flores-Crespo C.,
    8. Mantri R. V.

    Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System. PDA J. Pharm. Sci. Technol. 2019, 73 (6), 572–587.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Ovadia R.,
    2. Streubel A.,
    3. Webb-Vargas Y.,
    4. Ulland L.,
    5. Luemkemann J.,
    6. Rauch K.,
    7. Eder J.,
    8. Lam P.,
    9. Tegoulia V.,
    10. Maa Y.-F.

    Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2019, 73 (1), 2–15.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Mathaes R.,
    2. Mahler H.-C.,
    3. Roggo Y.,
    4. Ovadia R.,
    5. Lam P.,
    6. Stauch O.,
    7. Vogt M.,
    8. Roehl H.,
    9. Huwyler J.,
    10. Mohl S.,
    11. Streubel A.

    Impact of Vial Capping on Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2016, 70 (1), 12–29.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Jones D. R. H.,
    2. Ashby M. F.

    Engineering Materials 1: An Introduction to Properties, Applications and Design, 5th ed; Elsevier, 2019.
26. 26.↵
    1. Authelin J.-R.,
    2. Rodrigues M. A.,
    3. Tchessalov S.,
    4. Singh S. K.,
    5. McCoy T.,
    6. Wang S.,
    7. Shalaev E.

    Freezing of Biologicals Revisited: Scale, Stability, Excipients, and Degradation Stresses. J. Pharm. Sci. 2020, 109 (1), 44–61.

    OpenUrl
27. 27.↵
    1. Rayfield W. J.,
    2. Kandula S.,
    3. Khan H.,
    4. Tugcu N.

    Impact of Freeze/Thaw Process on Drug Substance Storage of Therapeutics. J. Pharm. Sci. 2017, 106 (8), 1944–1951.

    OpenUrl